Heptares Therapeutics | Evaluate

Snippet roundup: Immuno-oncology hopes for Parkinson's class, Coherus climbs

M&A – without Shaxalta a meagre quarter

February 23, 2015

Heptares takes Sosei out of its comfort zone

December 18, 2013

Despite Targacept and other setbacks, Alzheimer’s remains hot

June 27, 2013

Heptares raises $21m as cognition candidate approaches clinic

May 10, 2013

Forest takes heart at Trevena’s GPCR research

September 12, 2011

Takeda trial move could open up new diabetes treatment option

May 31, 2011

EP Vantage Interview - Heptares keeps up deal pace with Astra discovery pact

April 22, 2010

Therapeutic focus - A2A antagonists lining up to enter final stage Parkinson's trials

April 22, 2010

EP Vantage Interview - Heptares seeking partner to back clinical work

October 14, 2009

Vantage Point – Corporate VCs plugging the gap